CLINICAL_TRIALS
research
· 2025-08-20
Clinical Trial Update: A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Summary
A clinical trial update evaluating a block-and-replace strategy using Osilodrostat with concurrent glucocorticoid replacement for endogenous Cushing syndrome wi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan | Conditions: Endogenous Cushing Syndrome, Adrenal Insufficiency | Status: RECRUITING